Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented,“The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback